Logo
Home|Clinics & Hospitals|Departments or Services|Insurance Companies|Health News|Contact Us
HomeClinics & HospitalsDepartments or ServicesInsurance CompaniesHealth NewsContact Us

Search

Health News

Joint clinical practice guideline from American Heart Association/American College of Cardiology

Date: Nov-14-2013
Eating an overall heart-healthy diet and being physically active is critical for preventing heart attacks, strokes and other cardiovascular diseases according to a new lifestyle guideline.The joint clinical practice guideline from the American Heart Association and the American College of Cardiology was published online in the American Heart Association journal Circulation, and the Journal of the American College of Cardiology.

Joint clinical practice guideline from American Heart Association/American College of Cardiology

Date: Nov-14-2013
Eating an overall heart-healthy diet and being physically active is critical for preventing heart attacks, strokes and other cardiovascular diseases according to a new lifestyle guideline.The joint clinical practice guideline from the American Heart Association and the American College of Cardiology was published online in the American Heart Association journal Circulation, and the Journal of the American College of Cardiology.

New guideline for management of blood cholesterol published by ACC/AHA

Date: Nov-14-2013
The American College of Cardiology and the American Heart Association have released a new clinical practice guideline for the treatment of blood cholesterol in people at high risk for cardiovascular diseases caused by atherosclerosis, or hardening and narrowing of the arteries, that can lead to heart attack, stroke or death.The guideline identifies four major groups of patients for whom cholesterol-lowering HMG-CoA reductase inhibitors, or statins, have the greatest chance of preventing stroke and heart attacks.

New guideline for management of blood cholesterol published by ACC/AHA

Date: Nov-14-2013
The American College of Cardiology and the American Heart Association have released a new clinical practice guideline for the treatment of blood cholesterol in people at high risk for cardiovascular diseases caused by atherosclerosis, or hardening and narrowing of the arteries, that can lead to heart attack, stroke or death.The guideline identifies four major groups of patients for whom cholesterol-lowering HMG-CoA reductase inhibitors, or statins, have the greatest chance of preventing stroke and heart attacks.

Roadmap to treat adults affected by obesity, overweight

Date: Nov-14-2013
Healthcare providers are on the front line of the obesity epidemic - poised to identify who needs to lose weight for health reasons and in a prime position to direct successful weight loss efforts. The American Heart Association, American College of Cardiology and Obesity Society have developed comprehensive treatment recommendations to help healthcare providers tailor weight loss treatments to adult patients affected by overweight or obesity.

Roadmap to treat adults affected by obesity, overweight

Date: Nov-14-2013
Healthcare providers are on the front line of the obesity epidemic - poised to identify who needs to lose weight for health reasons and in a prime position to direct successful weight loss efforts. The American Heart Association, American College of Cardiology and Obesity Society have developed comprehensive treatment recommendations to help healthcare providers tailor weight loss treatments to adult patients affected by overweight or obesity.

Link between geographic patterns and death rates in US drug poisonings

Date: Nov-14-2013
A new study published in the American Journal of Preventive Medicine gives new insight into the geographic variation in drug poisoning mortality, with both urban centers and rural areas showing a large increase in death rates. While previous studies have looked at drug poisoning related deaths in broad strokes, this is the first study to examine them on the county level across the entire U.S.Drug poisoning is now the leading cause of injury death in the U.S. and has increased by more than 300 percent over the last three decades.

Link between geographic patterns and death rates in US drug poisonings

Date: Nov-14-2013
A new study published in the American Journal of Preventive Medicine gives new insight into the geographic variation in drug poisoning mortality, with both urban centers and rural areas showing a large increase in death rates. While previous studies have looked at drug poisoning related deaths in broad strokes, this is the first study to examine them on the county level across the entire U.S.Drug poisoning is now the leading cause of injury death in the U.S. and has increased by more than 300 percent over the last three decades.

New technology combining contraception, HIV and herpes simplex virus-2 prevention

Date: Nov-14-2013
CONRAD Head of drug delivery, Meredith Clark, PhD, presented preclinical data on a new intravaginal ring that provides contraception as well as HIV-1 and HSV-2 prevention at the 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in San Antonio, Texas. This multipurpose prevention technology (MPT) can remain in the vagina for up to 90 days and releases the contraceptive levonorgestrel (LNG) and tenofovir (TFV), an antiretroviral that inhibits HIV and HSV replication in susceptible cells.The CONRAD product development team, in collaboration with Dr.

New technology combining contraception, HIV and herpes simplex virus-2 prevention

Date: Nov-14-2013
CONRAD Head of drug delivery, Meredith Clark, PhD, presented preclinical data on a new intravaginal ring that provides contraception as well as HIV-1 and HSV-2 prevention at the 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in San Antonio, Texas. This multipurpose prevention technology (MPT) can remain in the vagina for up to 90 days and releases the contraceptive levonorgestrel (LNG) and tenofovir (TFV), an antiretroviral that inhibits HIV and HSV replication in susceptible cells.The CONRAD product development team, in collaboration with Dr.